Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154

EFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII

Seth E Anderson Jr 1, Jack S Remington 1
PMCID: PMC2139672  PMID: 4132992

Abstract

Human macrophages derived from in vitro culture of peripheral blood monocytes were studied under a variety of conditions to determine their microbicidal capacity for the obligate intracellular protozoan, Toxoplasma gondii. The effect of macrophages on intracellular Toxoplasma was evaluated morphologically by light and phase microscopy and by autoradiography. When macrophages from dye test (DT)-negative or DT-positive individuals were infected with Toxoplasma in the presence of normal human serum, the organisms were able to multiply intracellularly with resultant destruction of the monolayer. Once organisms were intracellular, the presence of antibody-containing serum in the medium did not alter this inability of the macrophages to kill Toxoplasma. However, when Toxoplasma were incubated in the presence of heat-inactivated DT-positive serum just before infection of the monolayers, the intracellular organisms were inhibited or killed by normal macrophages. Attempts were made to activate macrophages in vitro to kill Toxoplasma. Macrophages incubated in the presence of sensitized lymphocytes and Streptokinase-Streptodornase (SK-SD) or Toxoplasma lysate antigen (TLA) were found to kill Toxoplasma when compared to macrophages incubated in the presence of lymphocytes from DT-negative individuals and TLA or lymphocytes alone. Thus, in vitro induction of resistance (both specifically and nonspecifically) in human macrophages was accomplished by culturing these cells in the presence of specifically sensitized lymphocytes and antigen. These results suggest that, as in the mouse model, activated human macrophages have the ability to inhibit or kill intracellular Toxoplasma and that these cells may be important as effector cells in cell-mediated immunity (CMI) to toxoplasmosis in man.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abell C., Holland P. Acute toxoplasmosis complicating leukemia. Diagnosis by bone marrow aspiration. Am J Dis Child. 1969 Nov;118(5):782–787. doi: 10.1001/archpedi.1969.02100040784020. [DOI] [PubMed] [Google Scholar]
  2. Cline M. J. Bactericidal Activity of Human Macrophages: Analysis of Factors Influencing the Killing of Listeria monocytogenes. Infect Immun. 1970 Aug;2(2):156–161. doi: 10.1128/iai.2.2.156-161.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Diamond R. D., Bennett J. E. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun. 1973 Feb;7(2):231–236. doi: 10.1128/iai.7.2.231-236.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Drutz D. J., Cline M. J. Incorporation of tritiated thymidine by leprosy bacilli in cultures of human lepromatous macrophages. J Infect Dis. 1972 Apr;125(4):416–419. doi: 10.1093/infdis/125.4.416. [DOI] [PubMed] [Google Scholar]
  5. FRENKEL J. K., JACOBS L. Ocular toxoplasmosis; pathogenesis, diagnosis and treatment. AMA Arch Ophthalmol. 1958 Feb;59(2):260–279. [PubMed] [Google Scholar]
  6. Fowles R. E., Fajardo I. M., Leibowitch J. L., David J. R. The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med. 1973 Oct 1;138(4):952–964. doi: 10.1084/jem.138.4.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frenkel J. K. Adoptive immunity to intracellular infection. J Immunol. 1967 Jun;98(6):1309–1319. [PubMed] [Google Scholar]
  8. Gaines J. D., Gilmer M. A., Remington J. S. Deficiency of lymphocyte antigen recognition in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:117–121. [PubMed] [Google Scholar]
  9. Gambrill M. R., Wisseman C. L., Jr Mechanisms of immunity in typhus infections. 3. Influence of human immune serum and complement on the fate of Rickettsia mooseri within the human macrophages. Infect Immun. 1973 Oct;8(4):631–640. doi: 10.1128/iai.8.4.631-640.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gambrill M. R., Wisseman C. L., Jr Mechanisms of immunity in typhus infections. I. Multiplication of typhus rickettsiae in human macrophage cell cultures in the nonimmune system: influence of virulence of rickettsial strains and of chloramphenicol. Infect Immun. 1973 Oct;8(4):519–527. doi: 10.1128/iai.8.4.519-527.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Godal T., Rees R. J., Lamvik J. O. Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol. 1971 Apr;8(4):625–637. [PMC free article] [PubMed] [Google Scholar]
  12. Hanifin J. M., Cline M. J. Human monocytes and macrophages. Interaction with antigen and lymphocytes. J Cell Biol. 1970 Jul;46(1):97–105. doi: 10.1083/jcb.46.1.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JACOBS L., JONES F. E., MELTON M. L. The survival of Toxoplasmagondii in various suspending media. J Parasitol. 1952 Aug;38(4 SEC):293–297. [PubMed] [Google Scholar]
  14. Jones T. C., Hirsch J. G. The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J Exp Med. 1972 Nov 1;136(5):1173–1194. doi: 10.1084/jem.136.5.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Krahenbuhl J. L., Gaines J. D., Remington J. S. Lymphocyte transformation in human toxoplasmosis. J Infect Dis. 1972 Mar;125(3):283–288. doi: 10.1093/infdis/125.3.283. [DOI] [PubMed] [Google Scholar]
  16. Krahenbuhl J. L., Remington J. S. In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun. 1971 Oct;4(4):337–343. doi: 10.1128/iai.4.4.337-343.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Krahenbuhl J. L., Rosenberg L. T., Remington J. S. The role of thymus-derived lymphocytes in the in vitro activation of macrophages to kill Listeria monocytogenes. J Immunol. 1973 Oct;111(4):992–995. [PubMed] [Google Scholar]
  18. LYCKE E., LUND E., FALSEN E. THE EFFECT OF IMMUNE SERUM AND ACTIVATOR ON THE INFECTIVITY OF TOXOPLASMA GONDII FOR CELL CULTURE. Acta Pathol Microbiol Scand. 1965;63:206–220. doi: 10.1111/apm.1965.63.2.206. [DOI] [PubMed] [Google Scholar]
  19. Magliulo E., De Feo V., Stirpe A., Riva C., Scevola D. Enhanced in vitro phagocytic power of macrophages from PPD-stimulated skin sites in human subjects hypersensitive to PPD. Clin Exp Immunol. 1973 Jul;14(3):371–376. [PMC free article] [PubMed] [Google Scholar]
  20. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Remington J. S., Bloomfield M. M., Russell E., Jr, Robinson W. S. The RNA of toxoplasma gondii. Proc Soc Exp Biol Med. 1970 Feb;133(2):623–626. doi: 10.3181/00379727-133-34531. [DOI] [PubMed] [Google Scholar]
  22. Remington J. S., Krahenbuhl J. L., Mendenhall J. W. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun. 1972 Nov;6(5):829–834. doi: 10.1128/iai.6.5.829-834.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Remington J. S., Yagura T., Robinson W. S. The effect of rifampin on Toxoplasma gondii. Proc Soc Exp Biol Med. 1970 Oct;135(1):167–172. doi: 10.3181/00379727-135-35011. [DOI] [PubMed] [Google Scholar]
  24. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]
  25. Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
  26. Samuel D. R., Godal T., Myrvang B., Song Y. K. Behavior of Mycobacterium leprae in human macrophages in vitro. Infect Immun. 1973 Sep;8(3):446–449. doi: 10.1128/iai.8.3.446-449.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Simon H. B., Sheagren J. N. Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes. Cell Immunol. 1972 Jun;4(2):163–174. doi: 10.1016/0008-8749(72)90015-9. [DOI] [PubMed] [Google Scholar]
  28. Steigbigel R. T., Lambert L. H., Jr, Remington J. S. Phagocytic and bacterial properties of normal human monocytes. J Clin Invest. 1974 Jan;53(1):131–142. doi: 10.1172/JCI107531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. VISCHER W. A., SUTER E. Intracellular multiplication of Toxoplasma gondi in adult mammalian macrophages cultivated in vitro. Proc Soc Exp Biol Med. 1954 Jul;86(3):413–419. doi: 10.3181/00379727-86-21117. [DOI] [PubMed] [Google Scholar]
  30. van Furth R., Cohn Z. A., Hirsch J. G., Humphrey J. H., Spector W. G., Langevoort H. L. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ. 1972;46(6):845–852. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES